Abstract
Prion diseases are caused by an infectious agent constituted by a rogue protein called prion (PrPSc) of neuronal origin (PrPc) and are exemplified by Creutzfeldt-Jakob disease in humans and bovine spongiform encephalopathy in cattle. Considerable efforts have been made to understand the cerebral damage caused by these diseases but a clear comprehensive view cannot be achieved without defining the neurophysiological function of PrPc. This lack of information is in part attributable to our ignorance of the precise localization of PrPc in the brain neuronal cell. One relevant option to explore this aspect is to undertake PrP immunohistochemistry at the electron-microscopy level, knowing that this challenge raises major technical constraints. In describing the attempts and restrictions of the various approaches used, we review here the efforts that have been invested in this particular field of prionology. The common result emerging from these contributions is that the synapse could be the site at which PrPc exerts its critical activity. This location suggests, in the perspective of synaptic regulation, that PrPc can be assigned multiple biological functions and supports the novel concept that prion-like changes are involved in long-term memory formation. The synaptic trait of PrPc and PrPSc suggests that synapse loss is the key event in neuronal death. Interestingly, synaptic alterations are also considered to be predominant in the pathophysiological mechanism in Alzheimer, Parkinson and Huntington diseases. All these brain disorders, characterized by the formation of a specific amyloid protein of synaptic origin, can be classified under the heading of amyloidogenic synaptopathies.
Similar content being viewed by others
References
Arendt T (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the “Dr. Jekyll and Mr. Hyde concept” of Alzheimer’s disease or the yin and yang of neuroplasticity. Prog Neurobiol 71:83–248
Bailey CH, Kandel ER, Si K (2004) The persistence of long-term memory: a molecular approach to self-sustaining changes in learning-induced synaptic growth. Neuron 44:49–57
Bailly Y, Haeberlé AM, Blanquet-Grossard F, Chasserot-Golaz S, Grant N, Schulze T, Bombarde G, Grassi J, Cesbron JY, Lemaire-Vieille C (2004) Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain. J Comp Neurol 473:244–269
Barmada S, Piccardo P, Yamaguchi K, Ghetti B, Harris DA (2004) GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol Dis 16:527–537
Borchelt DR, Koliatsos VE, Guarnieri M, Pardo CA, Sisodia SS, Price DL (1994) Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem 269:14711–14714
Bouzamondo E, Milroy AM, Ralston HJ 3rd, Prusiner SB, DeArmond SJ (2000) Selective neuronal vulnerability during experimental scrapie infection: insights from an ultrastructural investigation. Brain Res 874:210–215
Bouzamondo-Bernstein E, Hopkins SD, Spilman P, Uyehara-Lock J, Deering C, Safar J, Prusiner SB, Ralston HJ 3rd, DeArmond SJ (2004) The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 63:882–899
Brown DR (2001) Prion and prejudice: normal protein and the synapse. Trends Neurosci 24:85–90
Butowt R, Davies P, Brown DR (2007) Anterograde axonal transport of chicken cellular prion protein (PrP(c)) in vivo requires its N-terminal part. J Neurosci Res 85:2567–2579
Campana V, Sarnataro D, Zurzolo C (2005) The highways and byways of prion protein trafficking. Trends Cell Biol 15:102–111
Carleton A, Tremblay P, Vincent JD, Lledo PM (2001) Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflugers Arch 442:223–229
Clinton J, Forsyth C, Royston MC, Roberts GW (1993) Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. NeuroReport 4:65–68
Coitinho AS, Freitas AR, Lopes MH, Hajj GN, Roesler R, Walz R, Rossato JI, Cammarota M, Izquierdo I, Martins VR, Brentani RR (2006) The interaction between prion protein and laminin modulates memory consolidation. Eur J Neurosci 24:3255–3264
Coitinho AS, Lopes MH, Hajj GN, Rossato JI, Freitas AR, Castro CC, Cammarota M, Brentani RR, Izquierdo I, Martins VR ( 2007) Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1. Neurobiol Dis 26:282–290
Colling SB, Khana M, Collinge J, Jefferys JG (1997) Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 755:28–35
Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG (1994) Prion protein is necessary for normal synaptic function. Nature 370:295–297
Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, Race R, Manson JC, Chesebro B, Oldstone MB (2005) Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 19:255–265
Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins JN, Perry VH (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17:2147–2155
Curtis J, Errington M, Bliss T, Voss K, MacLeod N (2003) Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 3:55–62
Davies HA, Kelly A, Dhanrajan TM, Lynch MA, Rodriguez JJ, Stewart MG (2003) Synaptophysin immunogold labelling of synapses decreases in dentate gyrus of the hippocampus of aged rats. Brain Res 986:191–195
DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221–235
Deleault NR, Lucassen RW, Supattapone S (2003) RNA molecules stimulate prion protein conversion. Nature 16:717–720
Della-Bianca V, Rossi F, Armato U, Dal-Pra I, Costantini C, Perini G, Politi V, Della Valle G (2001) Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106-126). J Biol Chem 276:38929–38933
Evergren E, Benfenati F, Shupliakov O (2007) The synapsin cycle: a view from the synaptic endocytic zone. J Neurosci Res 85:2648–2656
Fauré J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, Grange J, Schoehn G, Goldberg Y, Boyer V, Kirchhoff F, Raposo G, Garin J, Sadoul R (2006) Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 31:642–648
Fischer von Mollard G, Stahl B, Walch-Solimena C, Takei K, Daniels L, Khoklatchev A, De Camilli P, Sudhof TC, Jahn R (1994) Localization of Rab5 to synaptic vesicles identifies endosomal intermediate in synaptic vesicle recycling pathway. Eur J Cell Biol 65:319–326
Fournier JG (2000) Introduction to histological localization of prion proteins. Microsc Res Tech 50:1
Fournier JG, Escaig-Haye F (1999) In situ molecular hybridization techniques for ultra-thin sections. In: Hajibagheri MA (ed) Electron microscopy, methods and protocols. Methods in molecular biology. Humana, Totawa, pp 167–182
Fournier JG, Grigoriev V (2001) Prion diseases: contribution of high-resolution immunomorphology. J Cell Mol Med 50:76–88
Fournier JG, Escaig-Haye F, Billette de Villemeur T, Robain O (1995) Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. CR Acad Sci Paris 318:339–344
Fournier JG, Escaig-Haye F, Billette de Villemeur T, Robain O (1997) Synaptic aspects of cellular prion protein. In: Festoff B, Hantai D, Citron BA (eds) Advances in organ biology, vol 2. J AI Press, Greenwich, Connecticut, pp 99–111
Fournier JG, Escaig-Haye F, Grigoriev V (2000a) Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 50:76–88
Fournier JG, Kopp N, Streichenberger N, Escaig-Haye F, Langeveld J, Brown P (2000b) Electron microsocopy of brain amyloid plaques from a patient with new variant Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 99:637–642
Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863–5875
Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, Brentani RR (2000) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 76:85–92
Grigoriev V, Escaig-Haye F, Streichenberger N, Kopp N, Langeveld J, Brown P, Fournier JG (1999) Submicroscopic immunodetection of PrP in the brain of a patient with a new-variant of Creutzfeldt-Jakob disease. Neurosci Lett 264:57–60
Haeberlé A, Ribaut-Barassin C, Bombarde G, Mariani J, Hunsmann G, Grassi J, Bailly Y (2000) Synaptic prion protein immuno-reactivity in the rodent cerebellum. Microsc Res Tech 50:66–75
Herms J, Tings T, Gall, S, Madlung A, Giese A, Siebert H, Schurmann P, Windl O, Brose N, Kretzschmar H (1999) Evidence of presynaptic localization and function of the prion protein. J Neurosci 19:8866–8875
Herrera GA, Lowery MC, Turbat-Herrera EA (2000) Immunoelectron microscopy in the age of molecular pathology. Appl Immunohistochem Mol Morphol 8:87–97
Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, DeArmond SJ (2005) Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci USA 102:886–891
Jeffrey M, Goodsir CM, Fowler N, Hope J, Bruce ME, McBride PA (1996) Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V murine scrapie. Neurodegeneration 5:101–109
Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, Sayers AR, Brown DA, Fraser JR (2000) Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26:41–54
Keshet GI, Bar-Peled O, Yaffe D, Nudel U, Gabizon R (2000) The cellular prion protein colocalizes with the dystroglycan complex in the brain. J Neurochem 75:1889–1897
Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glockshuber R, Riek R, Billeter M, Wuthrich K, Oesch B (1997) Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390:74–77
Kovacs GG, Preusser M, Strohschneider M, Budka H (2005) Subcellular localization of disease-associated prion protein in the human brain. Am J Pathol 1661:287–294
Laine J, Marc ME, Sy MS, Axelrad H (2001) Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur J Neurosci 14:47–56
Laszlo L, Lowe J, Self T, Kenward N, Landon M, McBride T, Farquhar C, McConnell I, Brown J, Hope J (1992) Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol 166:333–341
Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305:673–676
Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS (2002) Intercellular transfer of the cellular prion protein. J Biol Chem 277:47671–47677
Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, Brentani RR, Linden R, Martins VR (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. Neuroscience 25:11330–11339
Lujan R (2004) Electron microscopic studies of receptor localization. Methods Mol Biol 259:123–136
Magalhaes AC, Silva JA, Lee KS, Martins VR, Prado VF, Ferguson SS, Gomez MV, Brentani RR, Prado MA (2002) Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 277:33311–33318
Magalhaes AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, Prado MA, Caughey B (2005) Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci 25:5207–5216
Maglio LA, Perez MF, Martins VR (2004) Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 131:58–64
Mahadevan A, Shankar SK, Yasha TC, Santosh V, Sarkar C, Desai AP, Satishchandra P (2002) Brain biopsy in Creutzfeldt-Jakob disease: evolution of pathological changes by prion protein immunohistochemistry. Neuropathol Appl Neurobiol 28:314–324
Mahendrasingam S, Wallam CA, Hackney CM (2003) Two approaches to double post-embedding immunogold labeling of freeze-substituted tissue embedded in low temperature Lowicryl HM20 resin. Brain Res Brain Res Protoc 11:134–141
Makarova A, Mikhailenko I, Bugge TH, List K, Lawrence DA, Strickland DK (2003) The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes. J Biol Chem 278:50250–50258
Mallozzi C, Di Stasi AM, Minetti M (1999) Activation of src tyrosine kinases by peroxynitrite. FEBS Lett 456:201–206
Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J (2007) Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53:325–335
May P, Rohlmann A, Bock HH, Zurhove K, Marth JD, Schomburg ED, Noebels JL, Beffert U, Sweatt JD, Weeber EJ, Herz J (2004) Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol 24:8872–8883
McPherson PS, Czernik AJ, Chilcote TJ, Onofri F, Benfenati F, Greengard P, Schlessinger J, De Camilli P (1994) Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I. Proc Natl Acad Sci USA 91:6486–6490
Mironov A Jr, Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ (2003) Cytosolic prion protein in neurons. J Neurosci 23:7183–7193
Morris RJ, Parkyn CJ, Jen A (2006) Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett 580:5565–5571
Moya KL, Sales N, Hassig R, Creminon C, Grassi J, Di Giamberardino L (2000) Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech 50:58–65
Moya KL, Hassig R, Breen KC, Volland H, Di Giamberardino L (2005) Axonal transport of the cellular prion protein is increased during axon regeneration. J Neurochem 92:1044–1053
Nishina K, Deleault NR, Lucassen RW, Supattapone S (2004) In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 43:2613–2622
Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 368:81–90
Papassotiropoulos A, Wollmer MA, Aguzzi A, Hock C, Nitsch RM, Quervain DJ de (2005) The prion gene is associated with human long-term memory. Hum Mol Genet 14:2241–2255
Pinheiro TJ (2006) The role of rafts in the fibrillization and aggregation of prions. Chem Phys Lipids 141:66–67
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB (1998) Prions. Proc Nat Acad Sci USA 95:13363–13383
Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA (2007) Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J Neurosci Res 85:2741-2755
Riek R, Luhrs T (2003) Three-dimensional structures of the prion protein and its doppel. Clin Lab Med 23:209–225
Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153–161
Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P (2005) Prion clearance in bigenic mice. J Gen Virol 86:2913–2923
Salès N, Rodolfo K, Hassig R, Faucheux B, Di Giamberardino L, Moya KL (1998) Cellular prion protein localization in rodent and primate brain. Eur J Neurosci 10:2464–2471
Salès N, Fournier JG, Freire S, Burel M, Deslys JP, Lasmezas CI (2004) Immunohistochemical localization of prion protein in simian eyes (Abstract). Proceedings of the First International Conference of Neuroprion Network, Paris, no. 129
Santuccione A, Sytnyk V, Leshchyns’ka I, Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169:341–354
Scallet AC, Ye X (1997) Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann N Y Acad Sci 825:194–205
Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209–1225
Si K, Lindquist S, Kandel ER (2003) A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115:879–891
Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498:204–207
Spielhaupter C, Schatzl HM (2001) PrPC directly interacts with proteins involved in signaling pathways. J Bio Chem 76:44604–44612
Stevens CF (2004) Presynaptic function. Curr Opin Neurobiol 14:341–345
Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27:509–547
Taylor DR, Hooper NM (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 402:17–23
Ushkaryov YA, Petrenko AG, Geppert M, Sudhof TC (1992) Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 257:50–56
Valentino KL, Crumrine DA, Reichardt LF (1985) Lowicryl K4M embedding of brain tissue for immunogold electron microscopy. J Histochem Cytochem 33:969–973
Vassallo N, Herms J (2003) Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86:538–544
Waites CL, Craig AM, Garner CG (2005) Mechanisms of vertebrate synaptogenesis. Annu Rev Neurosci 28:251–274
Wiley CA, Burrola PG, Buchmeier MJ, Wooddell MK, Barry RA, Prusiner SB (1987) Immunogold localization of prion filaments in scrapie-infected hamster brain. Lab Invest 57:646–656
Wilkinson RS, Lin MY (2004) Endocytosis and synaptic plasticity: might the tail wag the dog? Trends Neurosci 27:171–174
Yun SW, Gerlach M, Riederer P, Klein MA (2006) Oxidative stress in the brain at early preclinical stages of mouse scrapie. Exp Neurol 201:90–98
Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, Oliveira E de, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21:3307–3316
Zhai RG, Bellen HJ (2004) The architecture of the active zone in the presynaptic nerve terminal. Physiology (Bethesda) 19:262–267
Acknowledgements
I wish to thank S. Braithwaithe, M.M. Ruchoux, and S. Simoneau for editing the manuscript and A. Roig for the design work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fournier, JG. Cellular prion protein electron microscopy: attempts/limits and clues to a synaptic trait. Implications in neurodegeneration process. Cell Tissue Res 332, 1–11 (2008). https://doi.org/10.1007/s00441-007-0565-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-007-0565-5